{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:40:06Z","timestamp":1793497206870,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016280","name":"Panjab University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016280","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2021\/005467"],"award-info":[{"award-number":["CRG\/2021\/005467"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bioorg.2026.109916","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T23:28:59Z","timestamp":1777073339000},"page":"109916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pyrazolo[1,5-c]quinazoline-based heterocycles exhibit potent antileishmanial activity: Mechanistic insights and toxicity profile"],"prefix":"10.1016","volume":"177","author":[{"given":"Sandeep","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kushvinder","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alka","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Bharti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak B.","family":"Salunke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhbir","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109916_bb0005","unstructured":"World Health OrganizationLeishmaniaisis Fact sheets2024https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/leishmaniasis2024 (accessed 8 November 2024)."},{"key":"10.1016\/j.bioorg.2026.109916_bb0010","doi-asserted-by":"crossref","unstructured":"O.A. Pilling J.L. Reis-Cunha C.A. Grace A.S. Berry M.W. Mitchell J.A. Yu C.R. Malekshahi E. Krespan C.K. Go C. Lombana Y.S. Song C.F. Amorim A.S. Lago L.P. Carvalho E.M. Carvalho D. Brisson P. Scott D.C. Jeffares D.P. Beiting , Selective whole-genome amplification reveals population genetics of leishmania braziliensis directly from patient skin biopsies, PLoS Pathog. 1932023 e101123010, doi: 1371\/journal.ppat.1011230.","DOI":"10.1371\/journal.ppat.1011230"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109916_bb0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1017\/S0031182022001640","article-title":"Revisiting epidemiology of leishmaniasis in central asia: lessons learnt","volume":"150","author":"Yurchenko","year":"2023","journal-title":"Parasitology."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109916_bb0020","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/cbdd.14227","article-title":"Leishmania species: A narrative review on surface proteins with structural aspects involved in host-pathogen interaction","volume":"102","author":"Kaushal","year":"2023","journal-title":"Chem. Biol. Drug Des."},{"issue":"7","key":"10.1016\/j.bioorg.2026.109916_bb0025","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1039\/D3MD00081H","article-title":"Biological activity and structure-activity relationship of dehydrodieugenol b analogues against visceral leishmaniasis","author":"Amaral","year":"2023","journal-title":"RSC Med. Chem.14"},{"key":"10.1016\/j.bioorg.2026.109916_bb0030","doi-asserted-by":"crossref","first-page":"156143","DOI":"10.1016\/j.cyto.2023.156143","article-title":"Exploring drug repositioning for leishmaniasis treatment: ivermectin plus polymeric micelles induce immunological response and protection against tegumentary leishmaniasis","volume":"164","author":"Freitas","year":"2023","journal-title":"Cytokine"},{"key":"10.1016\/j.bioorg.2026.109916_bb0035","doi-asserted-by":"crossref","first-page":"1096458","DOI":"10.3389\/fmed.2023.1096458","article-title":"Immunotherapy and immunochemotherapy in combating visceral leishmaniasis","author":"Yadagiri","year":"2023","journal-title":"Front. Med.10"},{"issue":"20","key":"10.1016\/j.bioorg.2026.109916_bb0040","doi-asserted-by":"crossref","first-page":"10369","DOI":"10.1021\/cr400552x","article-title":"Fruitful decade for antileishmanial compounds from 2002 to late 2011","volume":"114","author":"Hussain","year":"2014","journal-title":"Chem. Rev."},{"issue":"9","key":"10.1016\/j.bioorg.2026.109916_bb0045","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1080\/00397911.2020.1712609","article-title":"A review on synthetic approaches of heterocycles via insertion-cyclization reaction","volume":"50","author":"Pathan","year":"2020","journal-title":"Synth. Commun."},{"issue":"9","key":"10.1016\/j.bioorg.2026.109916_bb0050","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1128\/AAC.00520-11","article-title":"The 8-aminoquinoline analogue sitamaquine causes oxidative stress in leishmania donovani promastigotes by targeting succinate dehydrogenase","volume":"55","author":"Carvalho","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109916_bb0055","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2174\/1389557521666210913115116","article-title":"Some scaffolds as anti-leishmanial agents: A review","volume":"22","author":"Mahender","year":"2022","journal-title":"Mini Rev. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109916_bb0060","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/13543776.2018.1530217","article-title":"Synthetic toll-like receptor agonists for the development of powerful malaria vaccines: A patent review","volume":"28","author":"Kaur","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"issue":"90","key":"10.1016\/j.bioorg.2026.109916_bb0065","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/jpp\/rgab063","article-title":"Toll-like receptor-7\/8 agonist kill leishmania amazonensis by acting as pro-oxidant and pro-inflammatory agent","volume":"73","author":"Kaushik","year":"2021","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109916_bb0070","doi-asserted-by":"crossref","first-page":"102172","DOI":"10.1016\/j.cbpa.2022.102172","article-title":"Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics","volume":"70","author":"Kaur","year":"2022","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"7","key":"10.1016\/j.bioorg.2026.109916_bb0075","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1039\/D1MD00031D","article-title":"Structural evolution of toll-like receptor 7\/8 agonists from imidazoquinolines to imidazoles","volume":"12","author":"Kaushik","year":"2021","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109916_bb0080","doi-asserted-by":"crossref","first-page":"8346","DOI":"10.1021\/acs.jmedchem.4c00464","article-title":"Structure\u2013activity relationships toward the identification of a high-potency selective Human Toll-like Receptor-7 agonist","volume":"67","author":"Kaushik","year":"2024","journal-title":"J. Med. Chem."},{"issue":"19","key":"10.1016\/j.bioorg.2026.109916_bb0085","doi-asserted-by":"crossref","first-page":"7955","DOI":"10.1021\/jm500744f","article-title":"Determinants of activity at human toll-like receptors 7 and 8: quantitative structure-activity relationship (QSAR) of diverse heterocyclic scaffolds","volume":"57","author":"Yoo","year":"2014","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109916_bb0090","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1080\/13543776.2020.1825687","article-title":"Small molecule agonists of toll-like receptors 7 and 8: A patent review 2014-2020","volume":"30","author":"Kieffer","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109916_bb0095","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1021\/acs.jmedchem.3c01504","article-title":"Heterocyclic-modified imidazoquinoline derivatives: selective TLR7 agonist regulates tumor microenvironment against melanoma","volume":"67","author":"Ou","year":"2024","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109916_bb0100","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jhep.2007.02.025","article-title":"Oral resiquimod in chronic HCV infection: safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies","volume":"47","author":"Pockros","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bioorg.2026.109916_bb0105","doi-asserted-by":"crossref","first-page":"144078","DOI":"10.1016\/j.apsusc.2019.144078","article-title":"Niosomes as efficient drug delivery modules for encapsulation of toll-like receptor 7 agonists and IDO-inhibitor","volume":"505","author":"Rathee","year":"2020","journal-title":"Appl. Surf. Sci."},{"issue":"18","key":"10.1016\/j.bioorg.2026.109916_bb0110","doi-asserted-by":"crossref","first-page":"8137","DOI":"10.1021\/jm301066h","article-title":"Structure\u2013activity relationships in human toll-like receptor 8-active 2, 3-diamino-furo [2, 3-c] pyridines","volume":"55","author":"Salunke","year":"2012","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109916_bb0115","doi-asserted-by":"crossref","first-page":"101008","DOI":"10.1016\/j.jics.2023.101008","article-title":"Lignin nanoparticles as a novel carrier for efficacious delivery of toll like receptor 7\/8 agonist: physicochemical and in-vitro evaluation","volume":"100","author":"Sharma","year":"2023","journal-title":"J. Indian Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.109916_bb0120","unstructured":"S. Ugur, H.H.I. Bin, S. Stefan, R. Roman, TLR7 agonist and combinations for cancer treatment, WO 2023 (083868) (2023) A1."},{"issue":"10","key":"10.1016\/j.bioorg.2026.109916_bb0125","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1021\/acsmedchemlett.4c00200","article-title":"Modulation of the adjuvant potential of imidazoquinoline-based TLR7\/8 agonists via alum adsorption","volume":"15","author":"Kumar","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109916_bb0130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bioorg.2018.12.025","article-title":"Synthesis of novel quinoline-based thiadiazole, evaluation of their antileishmanial potential and molecular docking studies","volume":"85","author":"Almandil","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109916_bb0135","first-page":"2859637","article-title":"Synthesis, characterization, and antileishmanial activity of certain quinoline-4-carboxylic acids","author":"Abdelwahid","year":"2019","journal-title":"J. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109916_bb0140","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1128\/AAC.01299-10","article-title":"In vitro activities of new 2-substituted quinolines against Leishmania donovani","volume":"55","author":"Loiseau","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109916_bb0145","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1021\/acs.jmedchem.9b00628","article-title":"Synthesis, biological evaluation, structure\u2013activity relationship, and mechanism of action studies of quinoline\u2013metronidazole derivatives against experimental visceral leishmaniasis","volume":"62","author":"Upadhyay","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109916_bb0150","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cbi.2016.10.017","article-title":"Quinoline derivatives: Synthesis, leishmanicidal activity and involvement of mitochondrial oxidative stress as mechanism of action","volume":"260","author":"Coimbra","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2026.109916_bb0155","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.exppara.2016.10.009","article-title":"Aminoquinoline compounds: Effect of 7-chloro-4-quinolinylhydrazone derivatives against Leishmania amazonensis","volume":"171","author":"Antinarelli","year":"2016","journal-title":"Exp Parasitol"},{"issue":"9","key":"10.1016\/j.bioorg.2026.109916_bb0160","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.bmcl.2014.03.065","article-title":"Design, synthesis, ADME characterization and antileishmanial evaluation of novel substituted quinoline analogs","volume":"24","author":"Gopinath","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bioorg.2026.109916_bb0165","doi-asserted-by":"crossref","first-page":"112956","DOI":"10.1016\/j.ejmech.2020.112956","article-title":"In vitro identification of imidazo[1,2-a]pyrazine-based antileishmanial agents and evaluation of L. major casein kinase 1 inhibition","volume":"210","author":"Bazin","year":"2021","journal-title":"Eur J Med Chem"},{"issue":"22","key":"10.1016\/j.bioorg.2026.109916_bb0170","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1021\/jm0401006","article-title":"Antileishmanial pyrazolopyridine derivatives: synthesis and structure\u2013activity relationship analysis","volume":"47","author":"de Mello","year":"2004","journal-title":"J. Med. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2026.109916_bb0175","doi-asserted-by":"crossref","first-page":"7451","DOI":"10.1016\/j.bmcl.2011.09.134","article-title":"Synthesis and antileishmanial evaluation of 1-aryl-4-(4,5-dihydro-1H-imidazol-2-yl)-1H-pyrazole derivatives","volume":"21","author":"M.S. dos Santos","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bioorg.2026.109916_bb0180","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejmech.2015.02.038","article-title":"New heterocyclic hybrids of pyrazole and its bioisosteres: design, synthesis and biological evaluation as dual acting antimalarial-antileishmanial agents","volume":"94","author":"Bekhit","year":"2015","journal-title":"Eur J Med Chem"},{"issue":"16","key":"10.1016\/j.bioorg.2026.109916_bb0185","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.4155\/fmc-2017-0120","article-title":"Synthesis, modeling and biological evaluation of hybrids from pyrazolo[1,5c]pyrimidine as antileishmanial agents","volume":"9","author":"Atta","year":"2017","journal-title":"Future Med Chem"},{"issue":"24","key":"10.1016\/j.bioorg.2026.109916_bb0190","doi-asserted-by":"crossref","first-page":"9615","DOI":"10.1021\/acs.jmedchem.5b01456","article-title":"Novel Amino-pyrazole Ureas with Potent In Vitro and In Vivo Antileishmanial Activity","volume":"58","author":"Mowbray","year":"2015","journal-title":"J Med Chem"},{"issue":"8","key":"10.1016\/j.bioorg.2026.109916_bb0195","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0223-5234(02)01388-0","article-title":"1,3-Diphenylpyrazoles: synthesis and antiparasitic activities of azomethine derivatives","volume":"37","author":"Rathelot","year":"2002","journal-title":"Eur. J. Med. Chem."},{"issue":"19","key":"10.1016\/j.bioorg.2026.109916_bb0200","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.4155\/fmc-2018-0058","article-title":"Synthesis, molecular modeling and biological screening of some pyrazole derivatives as antileishmanial agents","volume":"10","author":"Bekhit","year":"2018","journal-title":"Future Med Chem"},{"issue":"5","key":"10.1016\/j.bioorg.2026.109916_bb0205","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3390\/biomedicines10051124","article-title":"A review of the recent development in the synthesis and biological evaluations of pyrazole derivatives","volume":"10","author":"Ebenezer","year":"2022","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.bioorg.2026.109916_bb0210","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.3390\/molecules27092775","article-title":"1 H-pyrazolo [3, 4-b] quinolines: synthesis and properties over 100 years of research","volume":"27","author":"Danel","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109916_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202501053","article-title":"Design and synthesis of a new pyrazolo[1,5-c]quinazolin-5-amine as a potential TLR7\/8 modulator","volume":"21","author":"Kumar","year":"2026","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2026.109916_bb0220","doi-asserted-by":"crossref","first-page":"11530","DOI":"10.1039\/C8CC05845H","article-title":"Relay tricyclic Pd(II)\/Ag(I) catalysis: design of a four-component reaction driven by nitrene transfer on isocyanide yields inhibitors of EGFR","volume":"54","author":"Sawant","year":"2018","journal-title":"Chem. Commun."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109916_bb0225","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00436-024-08199-w","article-title":"Piperine, quercetin, and curcumin identified as promising natural products for topical treatment of cutaneous leishmaniasis","volume":"123","author":"Clemente","year":"2024","journal-title":"Parasitol. Res."},{"issue":"19","key":"10.1016\/j.bioorg.2026.109916_bb0230","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1080\/17568919.2025.2559574","article-title":"Desmuramyl peptide, a NOD2 agonist, enhanced immune response and parasite clearance in Leishmania donovani infection","volume":"17","author":"Kaur","year":"2025","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109916_bb0235","doi-asserted-by":"crossref","unstructured":"S. Kaur, S. Thakur, K. Kumar, S. Kaur, S, D.B. Salunke, Tuning Th1 Immunity through a TLR7\/8 Agonist HYBRID2-Formalin-Killed Leishmania donovani Antigen Immunomodulatory System in Visceral Leishmaniasis, ACS Appl. Bio Mater. 9 (7) (2026) 3518\u20133528, doi:10.1021\/acsabm.5c02526.","DOI":"10.1021\/acsabm.5c02526"},{"key":"10.1016\/j.bioorg.2026.109916_bb0240","doi-asserted-by":"crossref","unstructured":"C.A. Antwi, C.M. Amisigo, J.P. Adjimani, T.M. Gwira, In vitro activity and mode of action of phenolic compounds on Leishmania donovani. PLoS Negl. Trop. Dis. 13 (2) (2019) e0007206, doi:10.1371\/journal.pntd.0007206.","DOI":"10.1371\/journal.pntd.0007206"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109916_bb0245","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41598-020-77066-2","article-title":"Bioassay-based Corchorus capsularis L. leaf-derived \u03b2-sitosterol exerts antileishmanial effects against Leishmania donovani by targeting trypanothione reductase","volume":"10","author":"Pramanik","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.109916_bb0250","doi-asserted-by":"crossref","first-page":"102986","DOI":"10.1016\/j.bioorg.2019.102986","article-title":"Targeting malaria and leishmaniasis: synthesis and pharmacological evaluation of novel pyrazole-1, 3, 4-oxadiazole hybrids. Part II","volume":"89","author":"Verma","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109916_bb0255","doi-asserted-by":"crossref","first-page":"130042","DOI":"10.1016\/j.bmcl.2024.130042","article-title":"Brominated chalcones as promising antileishmanial agents","volume":"116","author":"Barreto","year":"2025","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109916_bb0260","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3390\/antibiotics14111123","article-title":"Novel chalcone derivatives as anti-Leishmania infantum agents with potential synergistic activity and in silico insights","volume":"14","author":"Fernandes","year":"2025","journal-title":"Antibiotics"},{"issue":"10","key":"10.1016\/j.bioorg.2026.109916_bb0265","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.ejmech.2007.02.010","article-title":"Synthesis and antileishmanial activity of 6-mono-substituted and 3, 6-di-substituted acridines obtained by acylation of proflavineEur","volume":"42","author":"Di Giorgio","year":"2007","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826004529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826004529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T11:21:05Z","timestamp":1783077665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826004529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":53,"alternative-id":["S0045206826004529"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109916","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyrazolo[1,5-c]quinazoline-based heterocycles exhibit potent antileishmanial activity: Mechanistic insights and toxicity profile","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109916","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109916"}}